CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating activities
Net income	$ 7,804	$ 1,814
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,985	2,062
Amortization of deferred financing costs charged to interest expense	151	210
Stock-based compensation expense	500	458
Deferred taxes, net	0	626
Changes in operating assets and liabilities
Accounts receivable	(13,396)	(12,344)
Other current assets	(632)	284
Accrued payroll	1,851	(538)
Deferred revenue	(12,125)	0
Accounts payable, accrued expenses, and other current liabilities	(2,335)	(1,185)
Other long-term assets and liabilities	42	95
Net cash used in operating activities	(16,155)	(8,518)
Investing activities
Purchase of equipment and improvements	0	(53)
Net cash used in investing activities	0	(53)
Financing activities
Proceeds from debt obligations	6,000	9,150
Repayment of debt obligations	(9,875)	(1,750)
Payment of deferred financing costs	0	(41)
Proceeds from issuance of common stock upon exercise of options and warrants	200	225
Net cash provided by (used in) financing activities	(3,675)	7,584
Net change in cash and cash equivalents	(19,830)	(987)
Cash and cash equivalents at beginning of period	24,051	1,357
Cash and cash equivalents at end of period	4,221	370
Supplemental disclosure of cash flow information
Cash paid during the period for interest	$ 513	$ 852